Genome wide analysis of TLR1/2- and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands by Töröcsik, Dániel et al.
RESEARCH ARTICLE
Genome wide analysis of TLR1/2- and TLR4-
activated SZ95 sebocytes reveals a complex
immune-competence and identifies serum
amyloid A as a marker for activated
sebaceous glands
Da´niel To¨rőcsik1,2*, Do´ra Kova´cs1, Szila´rd Po´liska3, Zita Szentkereszty-Kova´cs1,
Marianna Lova´szi1, Katalin Hegyi1, Andrea Szegedi1,4, Christos C. Zouboulis5,
Mona Ståhle2
1 Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 2 Unit of
Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital,
Stockholm, Sweden, 3 Department of Biochemistry and Molecular Biology, Genomic Medicine and
Bioinformatics Core Facility, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 4 Division of
Dermatological Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 5 Departments
of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical
School Theodore Fontane, Dessau, Germany
* dtorocsik@gmail.com
Abstract
Toll-like receptors (TLR) 2 and 4 are active in sebaceous glands and play a central role in
the development of acne. Still, there is only limited knowledge on their effect on sebocytes.
In this work we performed global gene expression profile analysis with functional clustering
of the differentially regulated genes of TLR1/2 (PAM3CSK4)- and TLR4 (lipopolysaccharide
[LPS])-activated SZ95 sebocytes. Both TLR1/2- and 4-activation promoted inflammation in
a similar manner already at an early time-point (6 hours), regulating genes involved in
inflammation, wound healing and chemotaxis reflecting a more complex cytokine and che-
mokine regulation than previously known. Importantly, lipid metabolism, the primary feature
of sebocytes, was affected at the level of gene expression only at a later time point (24
hours) indicating that sebocytes prioritize to exert a pro-inflammatory phenotype when con-
fronted with a danger signal. Supporting the biological relevance of our results, a meta-anal-
ysis revealed that the genes showing the strongest up-regulation were also found up-
regulated in acne. Of these genes, serum amyloid A 1/2 (SAA1/2) was confirmed to be a
suitable protein marker for in vivo activated sebocytes, underlining their immune-compe-
tence, which is structurally defined within sebaceous glands of acne and rosacea skin sam-
ples. Altogether our findings demonstrate that sebocytes are not only positioned at the end
point of inflammation but are actively involved in shaping the inflammatory response with
putative diagnostic and therapeutic relevance.
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Introduction
To elucidate the complexity of acne pathogenesis, histological analysis complemented with
genome wide expression profiling of lesional tissue samples has lately been performed [1–3].
Although the detected gene signatures could be paired with the inflammatory cell types accu-
mulating around the sebaceous glands, such as macrophages/dendritic cells, neutrophils and
Th17 lymphocytes [4], minor attempts were made to define the contribution of sebaceous
glands to these inflammatory profiles. Such studies could answer whether sebocytes, not only
contribute to the lipid barrier of the skin but also might be actively involved in shaping the
inflammatory response [1, 5–14].
Sebocytes are able to respond to a wide repertoire of stimuli like pathogens, lipids and hor-
mones reflecting the diversity of signals that could impact both the pathology as well as the
possible treatment options in sebaceous gland-associated diseases, such as acne [15]. Of these
factors, Propionibacterium acnes (P. acnes), a Gram-positive bacterium present in the skin
microbiome of acne prone areas [16], has gained a prime position [17–21], which by produc-
ing enzymes, such as lipases, proteinases and hyaluronidases could modify the composition of
sebum [22]. Moreover, through the activation of TLR2, also expressed and regulated in sebo-
cytes, P. acnes and its compounds could contribute to inflammation [8, 9, 23–27]. Supporting
a role for other members of the microbiome, like Gram-negative bacteria, in the pathogenesis
of acne, results showed that lipopolysaccharides (LPS; a Gram-negative bacteria-derived stim-
ulus signaling through the TLR4 pathway) were also able to induce the expression of cytokines
and chemokines, such as interleukin-6 (IL-6) and C-X-C Motif Chemokine Ligand 8 (CXCL-
8) in sebocytes [10], which were detected also in in vivo sebaceous glands of acne samples [4, 7,
28]. In addition, antimicrobial peptides, such as human beta-defensin-2 [10], were also
induced in response to LPS, whereas increased expression levels of cyclooxygenase-2 (COX-2),
prostaglandin F2 alpha (PGF2a) and pro matrix metalloprotease-2 (proMMP-2) were also
reported in LPS-treated hamster sebaceous glands [29]. These results indicate that TLR2 and 4
signaling pathways have a pivotal role in affecting sebocyte functions under pathological con-
ditions and thus makes it relevant to characterize those in more details. Moreover, the question
was raised whether the two TLR receptors mediate the same changes in sebocytes or have
somewhat different effects, like in peripheral blood mononuclear cells (PBMCs) [9, 30–32].
In the present study, we aimed to provide answers at the level of gene expression regulation,
gene expression profiling and pathway analysis of the altered genes by performing next genera-
tion high throughput sequencing in SZ95 sebocytes treated with specific synthetic TLR1/2 and
TLR4 activators. By using meta-analysis of already available gene expression profile data from
whole tissue samples of acne lesions [2], we also extended our work to define the magnitude of
sebaceous gland contribution to inflammation. In addition, based on our gene expression data
we aimed to identify a biomarker for activated sebaceous glands under in vivo conditions,
which may be of diagnostic and therapeutic relevance.
Materials and methods
Cell culture and treatments
The SZ95 immortalized human sebaceous gland cell line [33] was cultured at 37˚C in a humid-
ified atmosphere containing 5% (v/v) CO2 in Sebomed Basal Medium1 (Biochrom, Cam-
bridge, UK) supplemented with 10% fetal bovine serum ([FBS], Biowest, Nuaille´, France), 1
mM CaCl2, 1% penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO, USA) and 5 ng/ml epi-
dermal growth factor ([EGF], Sigma-Aldrich). When reaching approximately 80% confluence,
the medium was replaced with Sebomed Basal Medium1 containing 0.5% FBS, 1 mM CaCl2,
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1% penicillin/streptomycin, lacking EGF for 24 hours, followed by treatments with 1 μg/ml
PAM3CSK4 (TLR1/2 activator; dissolved in sterile water; Cat. no.: TLRL PMS, InvivoGen, San
Diego, CA, USA), 1 μg/ml LPS (TLR4 activator; derived from Escherichia coli; dissolved in
sterile water; Cat. no.: L4391, Sigma-Aldrich) or 50 μM arachidonic acid (dissolved in 98% eth-
anol; Cat. no.: A3611, Sigma-Aldrich).
ELISA measurements
In order to determine if the TLR1/2 and 4 activators (PAM3CSK4 and LPS) were efficient in
the treated samples, levels of IL-6 and CXCL-8 were measured (S1 Fig) with DuoSet ELISA
Development Kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturers’
instructions. SZ95 sebocyte supernatants were collected at 24 hours after PAM3CSK4 and LPS
treatments, and were aliquoted and stored at –20˚C until further analyses. Samples were mea-
sured in triplicates for each cytokine. One-way ANOVA and Dunnett post-hoc test were used
in the analyses of ELISA data.
Determination of mRNA levels
SZ95 sebocytes were cultured in the presence of TLR1/2 and 4 ligands (PAM3CSK4 and LPS,
respectively) or vehicle for 6 and 24 hours as described previously. Total RNA was isolated
using TRI Reagent (MRC, Cincinnati, OH, USA) according to the manufacturer’s protocol
and quantified by using NanoDrop 2000 (Thermo Fisher Scientific, Walthman, MA, USA).
For RNA sequencing (RNA-Seq) libraries were generated from 1 μg total RNA using Tru-
Seq RNA Sample Preparation Kit (Illumina, San Diego, CA, USA) according to the manufac-
turer’s protocol. Briefly, poly-A tailed RNAs were purified by oligodT-conjugated magnetic
beads and fragmented on 94˚C for 8 min, then 1st strand cDNA was transcribed using random
primers and SuperScript II reverse transcriptase (Life Technologies, Carlsbad, CA, USA). Fol-
lowing this step second strand cDNA was synthesized, the double-stranded cDNA was end-
repaired, 3’ ends were adenylated then Illumina index adapters were ligated. After adapter liga-
tion enrichment PCR was performed to amplify adapter ligated cDNA fragments. Fragment
size distribution and molarity of libraries were checked on Agilent BioAnalyzer DNA1000
chip (Agilent Technologies, Santa Clara, CA, USA). Concentrations of RNA-Seq libraries were
diluted to 10 nM and 5 libraries were pooled together before sequencing. Single read 50 bp
sequencing run was performed on Illumina HiScan SQ instrument (Illumina). Each library
pool was sequenced in one lane of sequencing flow cell, 16–18 million reads per sample was
obtained.
Analysis of RNA-Seq data
CASAVA software (Illumina) was used for pass filtering and demultiplexing process.
Sequenced reads were aligned to Human Genome v19 using TopHat and Cufflinks algorithms
and bam files were generated. Further statistical analyses were executed using NGS modul of
GeneSpring 12.6 software (Agilent Technologies). Relative mRNA expression levels were cal-
culated with DESeq algorithm. Aligned sequencing data have been deposited into the NCBI
SRA database under accession no.: SRP126626.
Western blot
Cells were washed in PBS and lysed in RIPA buffer containing a protease inhibitor mix (apro-
tinin, leupeptin, pepstatin, bestatin) (Sigma Aldrich). Proteins (20 μg) were separated by elec-
trophoresis using appropriate polyacrylamide gel and transferred to nitrocellulose membrane
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(Bio-Rad, Hercules, CA, USA). After blocking, membranes were probed with anti-SAA1
+SAA2 (Cat.no.: ab207445; Abcam, Cambridge, UK) antibody. The Ag–Ab complexes were
labeled with appropriate HRP-conjugated secondary antibody (Bio-Rad) and visualized by
WesternBright ECL HRP substrate (Advansta, CA, USA).
Histological samples
Anonymized formalin-fixed and paraffin embedded (FFPE) sections of human skin from the
tissue archive of the Department of Dermatology, University of Debrecen were acquired after
the approval of the Regional and Institutional Ethics Committee, University of Debrecen. At
least 5 different FFPE samples of each condition (healthy skin, papulopustular acne, papulo-
pustular rosacea) were evaluated. Samples were collected from the back of acne, from the face
of rosacea, and from matching skin areas of healthy individuals [34] who underwent surgery
with histologically later confirmed benign melanocytic lesions.
Immunohistochemistry
Slides from FFPE samples were deparaffinized and rehydrated. Endogenous peroxidase activ-
ity was blocked by treatment with 3% (v/v) H2O2 in distilled water for 15 min. Heat mediated
antigen retrieval was performed with Tris-EDTA buffer (Tris Base, 1mM EDTA solution,
0.05% Tween 20, pH 9). Nonspecific binding was blocked with 1% bovine serum albumin
(BSA) in PBS for 30 min at room temperature. Anti-SAA1+SAA2 (Cat. no.: ab 207445;
Abcam) antibody was diluted 1:200 in PBS and sections were incubated for 1 h at room tem-
perature in humidity chambers. For negative controls, the appropriate non-immune control
sera (rabbit IgG; Vector Laboratories, Burlingame, CA, USA) were used instead of the primary
antibody. HRP-conjugated secondary antibody was used in accordance with the manufactur-
er’s instructions (SuperSensitive One-step Polymer-HRP Detection System, BioGenex Labora-
tories, Fremont, CA, USA). Immunoreaction was visualized by Vector VIP Kit (Vector Labs.)
Sections were counterstained with methylene green. Images were acquired with a Leica
DM2000 LED microscope (Leica Microsystems, Wetzlar, Germany).
Oil Red O staining
SZ95 sebocytes were cultured on coverslips in the presence of TLR1/2 and 4 ligands
(PAM3CSK4 and LPS, respectively), arachidonic acid or vehicle for 24 and 48 hours as
described previously. Cells were fixed in 4% paraformaldehyde (Sigma-Aldrich) for 10 min.
Coverslips were placed in 100% propylene glycol (Amresco, Solon, OH, USA) for 1 min, fol-
lowed by a rinse with distilled water. Cells were stained with 0.7% Oil Red O (Sigma-Aldrich)
solution for 7 minutes then rinsed with 85% propylene glycol solutions. Nuclei were counter-
stained with hematoxylin and slides were covered using Mount Quick Aqueous mounting
medium (Bio Optica, Milano, Italy).
Results
Global transcriptome analysis reveals a permanent response of SZ95
sebocytes to TLR1/2 and 4 activators
To identify the transcriptional changes in sebocytes upon activation of TLR1/2 and TLR4 path-
ways, we treated SZ95 sebocytes with the specific, selective activators PAM3CSK4 (TLR1/2
pathway activator) and LPS (TLR4 pathway activator). By choosing a 6-hour time point for
our studies we focused on the initial changes, while the 24-hour time point allowed us to
address the ability of sebocytes to maintain their altered gene expression profile and thus their
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commitment towards inflammation (Fig 1A). Identifying the transcriptomes that reached a
significance in all biological triplicates at a given time point clearly fulfilled our criteria to
define genes with a statistically relevant altered expression.
As a first step, we focused on the changes at 6 hours and found a significant expression
change of approximately 500 genes in response to the administered TLR1/2 and TLR4 activa-
tors (505 in response to PAM3CSK4 and 437 in response to LPS). Next, we determined the
changes at 24 hours and found a further increase in the number of the differentially expressed
genes (611 in response to PAM3CSK4 and 558 in response to LPS). Interestingly, 43.3% (in
case of PAM3CSK4) and 60% (in case of LPS) of the genes from the 6-hour time point were
still having significantly changed expression levels at 24 hours (Fig 1B).
To assess the changes that were found at 6 but not at 24 hours we performed functional
clustering of the relevant genes also presented in a heat map form (S2A Fig). Interestingly, we
could not confirm a clear signature or function for these genes (S2B Fig) that could mark a bio-
logically relevant temporary effect of the applied stimuli.
These results altogether showed that the response of sebocytes to the used TLR activators is
not a transient state but induces long term changes in the genetic programs.
TLR1/2 and TLR4 signaling induces similar changes in the gene expression
profile of SZ95 sebocytes
To detect how close the two signaling pathways are in their effects on differential gene expres-
sion profiles, we compared the gene lists of both conditions of TLR-activated sebocytes from
the relevant time points. We found that the differentially expressed genes showed a prominent
overlap (320 out of 437 [LPS] and 505 [PAM3CSK4]) at 6 hours, while at 24 hours the gene
expression profile was almost identical (over 80% in case of PAM3CSK4 and 90% in case of
LPS) (Fig 2A).
Hierarchical clustering of the genes that were expressed and changed between any condi-
tions in unstimulated, TLR1/2- and TLR4-activated sebocytes exhibited changes mostly due to
up-regulation, as only approximately 20% of the genes were down-regulated. This prominent
induction in the number of regulated genes suggests that sebocytes respond to the activation
of the TLR 1/2 and TLR4 pathways by adding a new profile to their transcriptome rather than
losing the one from their untreated state. This was further supported by pathway analysis of
the down-regulated genes that could not sort them into any functional category.
The generated heat map also showed that of the genes reaching the level of significance at
24 but not at 6 hours, a very high number were already showing tendency of up-regulation at 6
hours, supporting that most of the changes observed at 24 hours occurred directly through the
applied TLR stimuli and that sebocytes were already committed at this early time point
towards their new profile (Fig 2B).
Functional clustering of the TLR1/2 and TLR4 responding genes in SZ95
sebocytes reveals an immediate change in immune response and only a
later one in lipid metabolism
To assess the biological response and functions that TLR1/2- and TLR4-activated sebocytes
could gain at the level of gene expression, we extended our studies with gene clustering and
pathway analysis of the altered genes at 6 and at 24 hours. Notably, as it was expected from the
previously detailed similarities in the genes regulated by TLR1/2 and TLR4 pathways, the func-
tional analysis also resulted in the same clusters in both treatments. This was confirmed by
using two independent softwares (Panther and Cytoscape pathway analysis programs).
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Analysis of the altered genes from the 6-hour time point revealed that the most significant
changes were related to genes involved in immune system/defense processes underpinning
that TLR 1/2 and TLR4 pathways are also fully active in sebocytes and are a potential link
between the inflammatory environment and the gene expression profile also in this cell type.
The gene clustering provided many interesting clusters, as well as novel ones, to sebocyte
research: such as a possible involvement in wound healing, regulation of cell proliferation, che-
motaxis and a more complex cytokine and chemokine production than what was previously
known besides the widely used detection of IL-6 and CXCL-8.
The analysis of the 24-hour samples found the same clusters as at 6 hours, which was in line
with the gene expression data showing that the changes at 6 hours were also consistent in the
24-hour samples. However, the cluster of cholesterol and steroid metabolic processes, which
represents the key function of sebocytes to produce lipids, was only affected at the 24-hour
time point (Table 1) with a significant up-regulation in the expression of the cluster forming
genes but with the exception of ABCG1 that was down-regulated (S1 Table). Importantly, this
also provides a possible explanation for our observations that no change was detected in the
lipid body formation of TLR1/2- and TLR4-activated sebocytes, which is the morphological
hallmark for an altered lipid metabolism (S3 Fig).
Altogether, these findings were surprising, since a cell type with a primary role to produce
lipids was not promptly changing its lipid profile on the level of gene expression or lipid body
formation. On the other hand, the experiments delivered interesting data on how rapidly sebo-
cytes could add the inflammatory status to their profile and accommodate to a new
environment.
Meta-analysis of gene expression profiles of acne samples and TLR1/2- and
TLR4-activated SZ95 sebocytes suggests a possible contribution of
sebocytes to disease associated inflammation
The available microarrays from whole tissue biopsies of acne samples (GSE53795) [2], histo-
logical analysis and in vitro experiments all suggested a role for the TLR1/2 and TLR4 pathways
[9, 23] in the pathogenesis of acne. However, no cell type-specific association with disease
development and inflammation was addressed in response to these stimuli. Therefore, as a
next step, a meta-analysis was performed using available gene expression data of acne whole
tissue samples [2] and the list of the up-regulated genes in TLR-stimulated SZ95 sebocytes to
determine possible genes and pathways with which sebocytes could integrate into the TLR2/
TLR4-acne cascade.
Using a Venn diagram to visualize the up-regulated genes in the acne samples compared to
healthy ones and in the TLR1/2- and TLR4-stimulated SZ95 sebocytes at 24 hours, a possible
contribution of sebocytes with 92 of the 900 significantly altered transcripts in acne could be
detected (Fig 3B).
Fig 1. Sebocytes respond to TLR 1/2 and 4 activation. (A) Experimental setting to detect the immediate and the later changes at the level of
gene expression regulation in sebocytes upon TLR1/2 and TLR4 activation. SZ95 sebocytes were cultured in the presence of PAM3CSK4 and
LPS to selectively and specifically activate the TLR1/2 and TLR4 pathways. Samples for RNAseq measurements were harvested at 6 and 24
hours after treatment, processed and measured as described in Materials and Methods. (B) Number of genes regulated by PAM3CSK4
(TLR1/2) or LPS (TLR4) in SZ95 sebocytes at early and late time points were identified and compared. The results are visualized as a Venn
diagram. The regulated mRNAs were categorized as early and late based on their significantly altered expression levels at 6 hours (red circle
for PAM3CSK4 and yellow for LPS) and 24 hours (blue circle for PAM3CSK4 and green for LPS) retrospectively when compared to
untreated cells. Note the large number of genes that are regulated already at 6 hours and the high number of overlapping genes in the 6 and
the 24 hour samples in response to both treatments.
https://doi.org/10.1371/journal.pone.0198323.g001
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Fig 2. TLR1/2 and TLR4 pathways induce similar changes in the gene expression profile of SZ95 sebocytes. (A)Venn diagram
visualizing genes that are regulated both by PAM3CSK4 and LPS in SZ95 sebocytes at 6 (orange) and 24 hours (dark blue). Note the large
number of genes that are regulated by both stimuli at 6 hours and an even greater number at 24 hours. (B) Differentially expressed genes in
untreated, LPS or PAM3CSK4 treated SZ95 sebocytes at 6 and 24 hours as observed by our RNAseq analysis shown as a heat map. Color
intensities reflect the ratios of signal intensities as shown. Note that the detected changes were due to a sustained up-regulation in the vast
majority of genes, while no genes with a significant down-regulation at both time-points were detected.
https://doi.org/10.1371/journal.pone.0198323.g002
Table 1. Clustering of the altered genes in response to TLR1/2 or TLR4 activation in SZ95 sebocytes. Genes that were regulated both by PAM3CSK4 and LPS were
functionally categorized using the Cytoscape classification system. The clusters clearly defined an immunocompetence for the activated sebocytes and pointed on so far
unrevealed functions such as a possible involvement in wounding and leukocyte migration. Note that in black are the genes/clusters present in both the early (6 hours) as
well as in the late responder (24 hours) group, while the genes in bold falling to the functional category of cholesterol metabolic process were only detected at 24 hours.
GO-ID p-value corr p-
value
Description Genes in test set
2376 1,46E-
38
4,38E-35 immune system process CXCL6|CSF3|CIITA|CSF2|CSF1|SECTM1|CXCL1|CXCL3|TNF|CXCL2| CTSS|IFI44L|CXCL5|ICAM1|
OASL|IFIH1|C4B|C4A|KYNU|DHX58|C1RL|TRIM25|JUNB|IKBKE|CD34|ICOSLG|TRIM22|SERPINB4|
EDN1|IL4R| IL1R1|DDX58|FST|WNT5A|TAP2|TAP1|TNFRSF1B|HLA-F|HLA-G|MMP9|TAPBP|OAS1|
OAS2|IL1B|IRF1|OAS3|LCP1|LTB|S100A|CFB|LTF|PTGER4|SELPLG|C1S|C1R|EBI3|NOD2|FYB|RELB|C3|
SBNO2|EBP|IFI16|NFIL3|IRAK2|CCL5|UBD|CCL2|APOL1|GBP2|TNFSF18|IL32| CD74|TGFB2|VCAM1|
CCL20|INHBA|SOD2|PML|NFKB2|BST2|NFKBI| CXCL10|CXCL11|IL6|VNN1|BCL6|IL8|BCL3|LCN2|
SAA1|TNFSF9|SAA|PTX3|IL7R
6955 4,97E-
32
7,47E-29 immune response CXCL6|CSF3|CIITA|CSF2|SECTM1|CXCL1|CXCL3|TNF|CXCL2|CTSS| IFI44L|CXCL5|ICAM1|OASL|
IFIH1|C4B|C4A|KYNU|DHX58|C1RL| TRIM25|IKBKE|TRIM22|SERPINB4|IL4R|IL1R1|DDX58|WNT5A|
TNFRSF1B|HLA-F|HLA-G|TAPBP|OAS1|OAS2|IL1B|OAS3|LCP1|LTB|CFB|LTF|PTGER4|C1S| C1R|EBI3|
NOD2|FYB|RELB|C3|SBNO2|NFIL3|CCL5|UBD|CCL2| APOL1|GBP2|TNFSF18|IL32|CD74|CCL20|
NFKB2|BST2|CXCL10| CXCL11|IL6|VNN1|IL8|BCL3|LCN2|TNFSF9|PTX3|IL7R
6952 3,98E-
31
3,99E-28 defense response CXCL6|CIITA|SERPINE1|CXCL1|CXCL3|TNF|CXCL2|IFIH1|C4B|C4A| KYNU|DHX58|C1RL|NFKBIZ|
BDKRB2|OLR1|TRIM25|AOX1|ICOSLG| IL1R1|DDX58|WNT5A|PLA2G4C|TAP1|F3|HLA-G|ADORA2A|
ELF3|IL1B|LAP3|S100A9|CFB|S100A8|IDO1|LTF|SAA3P|C1S|C1R|SAA4|NOD2|C3|IRAK2|CCL5|UBD|
CCL2|APOL1|APOL3|IL32|CD74|VCAM1|KLRC2|CCL20|MX2|STAT3|MX1|INHBA|NFKB1|ASS1|FOSL1|
CXCL10|CXCL11|IL6|VNN1|IL8|TNIP1|BCL3|LCN2|SAA1|SAA2|PTX3
9611 1,60E-
24
9,60E-22 response to wounding NRP1|CXCL6|CIITA|SERPINE1|ADM|CXCL1|CXCL3|TNF|CXCL2|C4B| THBD|C4A|PLAU|C1RL|
NFKBIZ|BDKRB2|OLR1|AOX1|IFNGR1| WNT5A|PLA2G4C|F3|EREG|PLSCR1|ADORA2A|LOX|ELF3|
IL1B|LAP3|S100A9|CFB|S100A8|IDO1|SAA3P|C1S|C1R|SAA4|TFPI|C3|IRAK2| CCL5|CCL2|APOL3|
TGFB2|VCAM1|CCL20|STAT3|SOD2|NFKB1|ASS1|CXCL10|CXCL11|IL6|VNN1|IL8|SAA1|SAA2|PTX3
6954 3,27E-
24
1,64E-21 inflammatory response SAA3P|CXCL6|CIITA|C1S|C1R|SAA4|CXCL1|CXCL3|TNF|CXCL2|C3| C4B|C4A|IRAK2|CCL5|C1RL|
NFKBIZ|BDKRB2|OLR1|CCL2|AOX1| APOL3|VCAM1|CCL20|STAT3|PLA2G4C|F3|NFKB1|ASS1|
CXCL10| CXCL11|IL6|VNN1|ADORA2A|IL8|ELF3|IL1B|SAA1|SAA2|PTX3|LAP3|S100A9|CFB|S100A8|
IDO1
6950 1,34E-
22
5,74E-20 response to stress SERPINE1|TNF|C4B|C4A|PLAU|DHX58|C1RL|TRIM25|ICOSLG|IL1R1|WNT5A|DIO2|TAP1|HLA-G|
EREG|LOX|LAP3|TRIB1|S100A9|CFB|S100A8|IDO1|INSIG1|ADRB2|C3|SOCS3|IRAK2|UBD|JUN|TGFB2|
VCAM1|KLRC2|DHCR24|INHBA| NFKB1|FOSL1|CXCL10|CXCL11|IL6|VNN1|BCL6|IL8|BCL3|MAFF|
LCN2|NRP1|CXCL6|CIITA|PCSK9|ADM|CXCL1|CXCL3|CXCL2|HK2| IFIH1|THBD|DUSP10|UCN2|
KYNU|NFKBIZ|BDKRB2|OLR1|AOX1| IKBKE|EDN1|IFNGR1|DDX58|PLA2G4C|F3|PLSCR1|ADORA2A|
ELF3| IL1B|ALDOC|SGK1|LTF|SAA3P|C1S|C1R|SAA4|NOD2|PTGS2|TFPI| IFI16|CCL5|CCL2|APOL1|
APOL3|IL32|ARNT2|CD74|CCL20|STAT1| MX2|STAT3|MX1|SOD2|AGT|ASS1|PML|TNIP1|SAA1|SAA2|
PTX3
42127 5,99E-
17
1,20E-14 regulation of cell
proliferation
NRP1|CSF3|IFITM1|CSF2|CSF1|SERPINE1|PTPRO|ADM|CXCL1|TNF| CXCL5|CDH5|PLAU|MYC|
NAMPT|BDKRB2|ICOSLG|TGM2|FGFBP1| EDN1|SP110|IGFBP3|WNT5A|SSTR1|F3|RUNX3|EREG|
ADORA2A| IL1B|MVD|TRIB1|IDO1|EBI3|ADRB2|PTGS2|CCL2|ARNT2|CD74|JUN|TGFB2|VCAM1|
STAT1|TNFRSF9|IL34|RARRES1|VEGFC|DHCR24| INHBA|SOD2|AGT|PML|FOSL2|FOSL1| NFKBIA|
CXCL10|IL6|BCL6|FAP|IL8|TNFSF9|DHCR7
8203 3,55E-
16
6,67E-14 cholesterol metabolic
process
IDI1|FDPS|MVK|HMGCS1|INSIG1|CYP51A1|PCSK9|DHCR24| HMGCR|LSS|ACAT2|SQLE|NSDHL|
EBP|FAP|MVD|DHCR7|APOL1| LDLR|APOL3|FDFT1
2526 6,81E-
13
7,58E-11 acute inflammatory
response
SAA3P|VCAM1|C1S|C1R|STAT3|SAA4|F3|ASS1|C3|C4B|C4A|IL6| VNN1|C1RL|SAA1|SAA2|CFB|APOL3
50900 3,99E-
12
3,99E-10 leukocyte migration TGFB2|SELPLG|VCAM1|CXCL3|TNF|ICAM1|IL6|IL8|CCL5|IL1B|SAA1|CCL2|SAA2|S100A9|CD34
https://doi.org/10.1371/journal.pone.0198323.t001
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Fig 3. Meta-analysis using gene expression profiles from acne samples, TLR1/2- and TLR4-activated SZ95 sebocytes reveals a possible contribution of
sebocytes to the inflammatory environment in acne. (A) Genes significantly up-regulated in acne samples (red circle) when compared to control samples and
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To assess how sebocytes may contribute to acne pathogenesis, further analysis was per-
formed using only the overlapping 92 genes (Fig 3A). The genes were grouped into functions
such as immune response, defense response, response to wounding, response to stress and che-
motaxis (Fig 3C).
Serum amyloid A 1/2 marks activated sebocytes and reveals structural
differences in the immune-competence of sebaceous glands
Next, we aimed to analyze and describe markers for TLR 1/2- and TLR4-mediated signaling in
sebocytes. The candidate genes, which showed the most robust induction upon PAM3CSK4
and LPS treatments, compared to non-stimulated sebocytes at both 6 and 24 hours were
selected from the RNAseq results. The list of 207 genes were then visualized in a Venn diagram
with the genes that were differentially regulated in acne samples when compared with healthy
control (Fig 4A). The overlapping 56 genes were subjected to hierarchical clustering to identify
the ones with the highest change of expression in all conditions and to choose the ones whose
expression showed a further increase from 6 to 24 hours in the stimulated SZ95 sebocytes (Fig
4B). As a result Serum Amyloid A 1/2 (SAA1/2)was identified to be suitable marker to identify
activated sebocytes at the level of gene expression (Fig 4C). Furthermore, correlating with the
mRNA data, the protein levels of SAA1/2 were also induced in TLR1/2 and 4 activated SZ95
sebocytes as revealed by Western blotting (Fig 4D).
To assess if the detection of SAA1/2 could also be applied and therefore be routinely used to
mark activated sebaceous glands at the protein level in histological specimens, we performed
immunohistochemistry using specific antibodies on normal as well as pathological skin sam-
ples such as papulopustular acne and papulopustular rosacea. SAA1/2 was successfully
detected, with prominent differences in the staining intensities of sebaceous glands in papulo-
pustular acne and papulopustular rosacea samples when compared with healthy skin. Impor-
tantly, SAA1/2 positivity had a characteristic distribution within the sebaceous glands in both
diseases, localizing exclusively at the basal cell layers, revealing a well-defined functional archi-
tecture of sebaceous glands regarding its immune-competence (Fig 5).
Discussion
To explore the possible functions for sebocytes under inflammatory conditions, we applied a
system-based approach of whole genome sequencing of SZ95 sebocytes, the best characterized
sebocyte line [33], treated with specific and selective TLR1/2 and TLR4 activators. This unbi-
ased strategy extends beyond the limits of previous studies that have only focused on a selected
set of proteins [35, 36]. With strict criteria in our statistical analysis and also applying profiles
of available gene expression data of whole tissue samples of acne lesions [2], we used all avail-
able tools to detect the differentially expressed genes in order to gain a step-by-step view and
follow-up on the accommodation of sebocytes to the TLR1/2 and TLR4 activators.
One of the most interesting findings in our study was that the TLR1/2 and TLR4 pathways
induced a similar change in the gene expression profile of the SZ95 sebocytes and that this
change was already present to a great extent at 6 hours. Pathway analysis of the altered genes
provided the same clusters regardless of the applied activator, which served to corroborate our
findings and further indicate so far unrevealed functionality for sebocytes under inflammatory
genes up-regulated in LPS (green circle) or PAM3CSK4 (blue circles) treated SZ95 sebocytes when compared to untreated cells at 24 hours are visualized as a
Venn diagram. Gene expression data of acne samples were obtained from available gene expression profiles (2). (B) Overlapping genes presented in a heat map
were functionally categorized using the Cytoscape classification system. (C) Biological process analysis by Cytoscape Analysis confirmed that sebocytes are
possible candidates for contributing to the inflammatory environment in acne samples.
https://doi.org/10.1371/journal.pone.0198323.g003
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conditions. Importantly, most of these clusters were also present in the meta-analysis of acne
whole tissue samples suggesting that sebocytes may contribute to disease-specific inflamma-
tory signatures as well. These findings, therefore, extend far beyond the complexity of the
genetic programs that are inducible in sebocytes and suggest that these cells may be active play-
ers in the pathogenesis of acne.
From the detected clusters, the one showing the most significant changes and also including
the highest number of genes was related to inflammation. Although this change was expected
based on previous results, still it was surprising to see that many of the cluster-forming genes
(C3, SERPINA3, IL6, VNN1, C1R, SAA1, SAA2 and CFB) encode for proteins that are known
serum markers for severe systemic inflammation in various diseases. Moreover, as revealed by
a number of genes (SERPINA3, TNFAIP6, C1R, SERPINE1, C3, THBD, PLAU, IRAK2, SOD2,
PLSCR1, VNN1, SAA1, SAA2, PTX3, S100A9, S100A8,CFB, and IDO1), sebocytes via their
products might also contribute to wound healing which is also a novel field yet to be character-
ized and could bring us closer to understand the background of acne-associated scarring.
Another interesting outcome of our analysis was the high number of cytokines induced at the
level of gene expression, which besides IL1β, IL6 and CXCL8, have not yet been characterized
in sebocyte research (CXCL1, CXCL2, CXCL3, CXCL10, CCL2 and CCL20). Further clustering
of these genes clearly showed that the wide repertoire of cytokines might have an effect on che-
motaxis and thus have a role in initiating inflammation. This has been addressed in our
recently published work, where after showing that TLR 2 and 4 activation of SZ95 sebocytes
led to an induction also in the levels of the measured proteins (CXCL-8, CXCL-10 CCL-5, IL-
6, G-CSF and VEGF) from the supernatants of cell cultures, we demonstrated a CXCL-
8-dependent chemotactic effect of sebocytes on neutrophils, monocytes and T cells [37].
Lipid metabolism, the primary function of sebocytes, is also greatly altered both in quantity
as well as in quality under inflammation as revealed with the analysis of sebum from patients
with acne as well as other diseases [21, 38–40]. Therefore, one of the most intriguing data from
our study was to see how the examined TLR pathways could influence lipid metabolism at the
level of gene expression. Unexpectedly, of the genes that encode proteins related to lipid
metabolism, a significant change and thus representation in the pathway clustering was only
detected in the 24-hour time point samples. However, at that time point, a great number of
genes from the steroid biosynthetic processes were altered (IDI1, FDPS. MVK. HMGCS1,
INSIG1, CYP51A1, PCSK9,DHCR24, HMGCR, LSS, ACAT2, SQLE, NSDHL, EBP, FAP, MVD,
DHCR7, APOL1, LDLR, APOL3, FDFT1 and ABCG1). Concluding on the enzymatic activity
based on gene expression result would be oversimplified, still these data provide a strong piece
of evidence, that sebocytes are indeed able to link inflammation to lipid metabolism in which
the TLR1/2 and TLR4 pathways could have a pivotal trigger effect [21, 40].
Altogether, the detected changes in the induced genes and their clustering allowed two
major conclusions: i., sebocytes are able to rapidly gain an immune-competent status in
Fig 4. Identifying Serum amyloid A 1/2 as a marker for inflamed sebocytes. (A)Venn diagram visualizing the number of genes showing
significantly different expression levels between treatment conditions (LPS and PAM3CSK4 treated SZ95 sebocytes at 6 and 24 hours when
compared to untreated SZ95 sebocytes) as observed by our RNAseq analysis. Note that 207 genes were identified as differentially regulated in
any of the examined conditions and time points, marked by yellow. (B) Venn diagram visualizing the overlap of the 207 genes and the
differentially regulated genes in acne samples from available gene expression profiles (2). Note that 56 out of the 207 genes were significantly
regulated also in acne samples. (C) Hierarchical clustering of the 56 genes that are differentially expressed in any of the conditions of LPS and
PAM3CSK4 treated SZ95 sebocytes when compared to untreated cells both at 6 and at 24 hours and are also significantly altered in acne
samples when compared to control ones as observed in the gene expression profiles of acne samples from the available work of Kelhala HL et al.
(NCBI GEO accession number: GSE5379) (2). Out of the 56 genes presented on the heat map, Serum amyloid A 1/2 is highlighted, fulfilling our
criteria (up-regulated in acne samples as well as by both treatments, its expression levels increased from 6 to 24 hours, detectable also at the level
of protein) to define a possible marker for inflamed sebocytes. (D) Western blot analysis of SAA1/2 in control, LPS and PAM3CSK4 treated
SZ95 sebocytes 24 h after treatment.
https://doi.org/10.1371/journal.pone.0198323.g004
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response either to TLR1/2 and or TLR4 activation. The clustering data fully support that sebo-
cytes are not simply lipid-metabolizing cells, but should also be challenged as inflammatory
modulators in a wide spectrum of dermatological diseases beyond acne. ii., The detected
inflammatory responses were neither TLR1/2- nor TLR4-specific, in other words sebocytes are
not able to sense and respond selectively to the two stimuli of different origin. This finding
gains its importance when put into the current concept of pathogen-related inflammation of
acne lesions suggesting that various stimuli, in and around the pilosebaceous unit capable of
activating the TLR2 and TLR4 pathways, might all be able to modulate the inflammatory status
of the sebaceous glands. Therefore, it is more likely that P. acnes has its specific role in acne
pathogenesis not (only) via the TLR2 pathway but with its various products that could interact
with the inflammatory pathways, which is definitely a challenging field for future studies [41,
42].
Another important outcome of our study was the identification of SAA1/2 as a marker pro-
tein for activated sebocytes, which might not only be a marker but could have a role as well in
various disease settings. SAA1/2 is predominantly produced by the liver and by adipocytes, in
strong association with the body mass [43], while its elevated serum concentration marks the
acute phase of inflammation. Moreover, SAA1 has been found to increase also in keratinocytes
in response to TLR2 activation, which was further augmented when glucocorticoids were used
in combination, suggesting a possible contribution of SAA to (steroid-induced) acne [44].
Importantly in our in vivo studies, sebocytes also stained strongly positive for SAA1/2 suggest-
ing that they may as well contribute to the levels of SAA1/2 in the local tissue environment and
perhaps even in the serum, which calls for further studies to assess it in acne patients. Besides
being a strong chemoattractant, SAAs also transport cholesterol that immediately puts forward
the question whether sebocyte-produced lipids may contribute not just to sebum but might
also make their way to the circulation via SAA. The finding that SAA has also been identified
as a danger signal that triggers activation and IL-1β secretion, a key cytokine in acne pathogen-
esis, sets altogether the basis for intriguing speculations on sebocyte derived SAA to be tested
as a possible therapeutic target [45]. Importantly, our finding that sebaceous glands were posi-
tive not just in acne samples, but also in rosacea supports, that sebaceous glands could be acti-
vated in other inflammatory conditions besides acne, with a pathomechanism and role yet to
be defined (15). Of further interest is the finding that SAA1/2 immunoreactivity was restricted
to the basal cells, similarly to what Alestas et al. have observed in the case of IL6 [7], suggesting
a functional compartmentalization, which deserves further exploration. This finding gains its
importance when answering the question what protects sebocytes from their own secreted lip-
ids, of which many are known inflammatory activators [46]. Based on our results we put for-
ward the hypothesis that while the basal cell layer is a potential immune responder part of the
sebaceous glands, with the maturation, the upper layers lose their immune-potential thus gain-
ing a possible protection against lipids. To identify the underlying changes is definitely a chal-
lenging field involving epigenetic as well as protein and signaling pathway studies.
In summary, our findings confirm that human sebocytes, with a primary role to metabolize
lipids, are able to rapidly acquire an immune-competent status when exposed to danger signals
Fig 5. Immunohistochemical detection of Serum Amyloid A 1/2 marks activated sebocytes and reveals a structurally defined immune-
competence in sebaceous glands. Immunohistochemical detection of SAA1/2 in human sebaceous glands in control skin as well as in papulopustular
acne and papulopustular rosacea. FFPE tissue samples were stained with rabbit monoclonal SAA1/2 antibody as described in the Materials and
Methods. Note that besides the increased staining intensities observed in papulopustular acne and papulopustular rosacea samples, SAA1/2 positivity
had a characteristic distribution within the sebaceous glands, localizing exclusively to the basal cell layers. Images are representative of at least 5 samples
from each disease and each staining. Staining intensities were independent of age and gender. Sections were counterstained with methylene green.
Original magnification: 50X, 200X.
https://doi.org/10.1371/journal.pone.0198323.g005
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and this function is structurally defined within the sebaceous glands. Thus sebocytes may not
just be at the end-point of inflammation but also contribute to disease development [7, 10, 11,
21, 28, 47–54]. Our data also put forward the need to revisit the role for the P. acnes–TLR2
pathway and to reveal the TLR2 independent effects of P. acnes as well, which could provide
clues to understand the exclusive pathogenic features of P. acnes in the pathogenesis of acne.
Moreover, we suggest that the different mechanisms that could regulate the levels of the TLR2
and 4 receptors, or interact with their signaling pathways [24, 25, 55] should be included more
into the concepts of acne pathogenesis and treatment options. By identifying SAA1/2 as
marker for immune-competent sebocytes, we also provided a useful research tool to extend
our knowledge on diseases which could be associated with sebaceous glands, and provide a
possible target for anti-inflammatory therapeutic interventions to treat sebaceous gland-asso-
ciated diseases.
Supporting information
S1 Fig. Levels of IL-6 and CXCL-8 in the supernatants of TLR1/2 (PAM3CSK4) and TLR4
(LPS) activated SZ95 sebocytes used for RNAseq analyses. Protein levels of IL-6 and CXCL-
8 were measured by ELISA as described in Materials and Methods. One-way ANOVA and
Dunnett post-hoc test were used in the data analyses (n = 3);  = p< 0.05,  = p<0.01,
 = p<0.0001.
(TIF)
S2 Fig. Heat map display of the genes with differential expression levels only at 6 hours.
(TIF)
S3 Fig. Oil Red O staining of lipid bodies in TLR1/2- (PAM3CSK4), TLR4- (LPS) activated
or arachidonic acid (AA) treated SZ95 sebocytes. Oil Red O staining revealed no changes in
the lipid body formation of TLR1/2- and TLR4-activated sebocytes neither at 24-hour nor at
48-hour time points. Arachidonic acid (AA) treatment inducing lipid body formation both in
numbers and size was used as a positive control. At least three independent samples were
stained per each treatment.
(TIF)
S1 Table. Genes involved in lipid metabolism with altered expression levels at 24 hours.
Note the significant up-regulation in the expression levels of the cluster forming genes with
the exception of ABCG1.
(DOCX)
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